I think there is a lot of confusion, especially in the patient community, about clinical research., explained Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network.
I think there is a lot of confusion, especially in the patient community, about clinical research, explained Bradley Prechtl, MBA, chief executive officer of Florida Cancer Specialists and the American Oncology Network.
Transcript
When offering clinical trials to patients, does this require dispelling misconceptions they might have about participating in a trial?
I think there is a lot of confusion, especially in the patient community, about clinical research. A lot of patients I think hear clinical research thinking they’re going to be some sort of guinea pig. They don’t know if it’s a real drug or a placebo or whatever the case may be. We’ve had so many patients that have been enrolled in clinical trials that were not progressing well with standard of care that they’ve had incredible outcomes. I think one of our goals is continuing to try and educate patients on what is clinical research and really dumbing it down because even people that are in healthcare, I think, often times have misconceptions about what clinical research really is.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More